Skip to main navigation Skip to search Skip to main content

Rektummukosametastase beim Prostatakarzinomrezidiv: 68Ga-PSMA-PET/CT ermöglicht eine gezielte Salvagestrahlentherapie

Translated title of the contribution: Rectal mucosa metastasis in recurrent prostate cancer: 68Ga-PSMA-PET/CT allows targeted salvage radiotherapy
  • Technical University of Munich
  • University Hospital Würzburg
  • Pathologisches Institut
  • Klinikum Ansbach

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

This article presents for the first time a case of rectal mucosa metastasis of recurrent prostate cancer that was diagnosed with 68Ga-PSMA PET/CT. After histological confirmation, the patient was treated with salvage radiotherapy. This case report underlines the specificity and efficacy of PSMA-based PET imaging. In case of biochemical relapse, it can be used even at low PSA levels to detect prostate cancer metastases that might also be in atypical locations. Thus, 68Ga-PSMA PET/CT may allow new options for salvage therapy.

Translated title of the contributionRectal mucosa metastasis in recurrent prostate cancer: 68Ga-PSMA-PET/CT allows targeted salvage radiotherapy
Original languageGerman
Pages (from-to)1086-1088
Number of pages3
JournalUrologe - Ausgabe A
Volume55
Issue number8
DOIs
StatePublished - 1 Aug 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Rectal mucosa metastasis in recurrent prostate cancer: 68Ga-PSMA-PET/CT allows targeted salvage radiotherapy'. Together they form a unique fingerprint.

Cite this